Evidence map›Paper›PMID 28488596›Full record

ArticleNanotechnology2017

The impact of microfluidic mixing of triblock micelleplexes on in vitro / in vivo gene silencing and intracellular trafficking.

Daniel P Feldmann, Yuran Xie, Steven K Jones, Dongyue Yu, Anna Moszczynska, Olivia M Merkel

Open access · greenAbstract read
In one paragraph

Article in Nanotechnology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Engineering poly- and micelleplexes for nucleic acid delivery - A reflection on their endosomal escape.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Review
  8. Can pulmonary RNA delivery improve our pandemic preparedness?Journal of controlled release : official journal of the Controlled Release Society · 2022
    Article
  9. Article
  10. Review
  11. Characterization of positively charged polyplexes by tunable resistive pulse sensing.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2021
    Article
  12. Inhaled RNA Therapy: From Promise to Reality.Trends in pharmacological sciences · 2020
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Daniel P FeldmannDepartment of Oncology, Wayne State University School of Medicine, 4100 John R St, Detroit, MI 48201, United States of America.ORCID 0000-0002-8148-9316
Yuran XieDepartment of Pharmaceutical Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48201, United States of America.
Steven K JonesDepartment of Oncology, Wayne State University School of Medicine, 4100 John R St, Detroit, MI 48201, United States of America.
Dongyue YuDepartment of Pharmaceutical Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48201, United States of America.
Anna MoszczynskaDepartment of Pharmaceutical Sciences, Wayne State University, 259 Mack Ave, Detroit, MI 48201, United States of America.ORCID 0000-0002-9927-2318
Olivia M MerkelDepartment of Oncology, Wayne State University School of Medicine, 4100 John R St, Detroit, MI 48201, United States of America.ORCID 0000-0002-4151-3916
Wayne State University · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
PROTEASOME AND PARKIN AS DRUG TARGETS AGAINST METHAMPHETAMINE TOXICITYR01DA034783 · NIDA · WAYNE STATE UNIVERSITY · PI MOSZCZYNSKA, ANNA · 2013 to 2017
$1.7M
European Research Council 637830NCI NIH HHS P30 CA022453NIDA NIH HHS R01 DA034783
6 · The paper itself

Abstract

The triblock copolymer polyethylenimine-polycaprolactone-polyethylene glycol (PEI-PCL-PEG) has been shown to spontaneously assemble into nano-sized particulate carriers capable of complexing with nucleic acids for gene delivery. The objective of this study was to investigate micelleplex characteristics, their in vitro and in vivo fate following microfluidic preparation of siRNA nanoparticles compared to the routinely used batch reactor mixing technique. Herein, PEI-PCL-PEG nanoparticles were prepared with batch reactor or microfluidic mixing techniques and characterized by various biochemical assays and in cell culture. Microfluidic nanoparticles showed a reduction of overall particle size as well as a more uniform size distribution when compared to batch reactor pipette mixing. Confocal microscopy, flow cytometry and qRT-PCR displayed the subcellular delivery of the microfluidic formulation and confirmed the ability to achieve mRNA knockdown. Intratracheal instillation of microfluidic formulation resulted in a significantly more efficient (p < 0.05) knockdown of GAPDH compared to treatment with the batch reactor formulation. The use of microfluidic mixing techniques yields an overall smaller and more uniform PEG-PCL-PEI nanoparticle that is able to more efficiently deliver siRNA in vivo. This preparation method may prove to be useful when a scaled up production of well-defined polyplexes is required.

Indexed as

A549 CellsCell Line, TumorChemistry, PharmaceuticalDrug CarriersGene SilencingGene Transfer TechniquesHumansMicrofluidicsNanoparticlesParticle SizePolyestersPolyethylene GlycolsPolyethyleneiminePolymersRNA, Small InterferingDrug CarrierspolycaprolactonePolyesterspoly(ethylene glycol)-co-poly(ethyleneimine)Polyethylene GlycolsPolyethyleneiminePolymersRNA, Small Interfering

Identifiers

PMID28488596
PMCPMC5539944
OpenAlexW2612906619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.